Y Intercept (Hong Kong) LTD Biotechnology

Y Intercept (Hong Kong) LTD

$3.75 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ABEO Abeona Therapeutics Inc.	$38.3M	$581,000 0.02% of portfolio	102,336	Q2 2025 New
ARCT Arcturus Therapeutics Holdings Inc.	$460M	$578,000 0.02% of portfolio	44,432	Q2 2025 Added 92.54%
BGNE Bei Gene, Ltd.	$23.5B	$527,000 0.01% of portfolio	2,328	Q2 2025 New
ELYM Eliem Therapeutics, Inc.	$109M	$525,000 0.01% of portfolio	127,952	Q2 2025 New
ARWR Arrowhead Pharmaceuticals, Inc.	$3.15B	$491,000 0.01% of portfolio	31,105	Q2 2025 New
JANX Janux Therapeutics, Inc.	$1B	$475,000 0.01% of portfolio	20,602	Q2 2025 Added 15.53%
TRVI Trevi Therapeutics, Inc.	$481M	$474,000 0.01% of portfolio	86,830	Q2 2025 New
TBPH Theravance Biopharma, Inc.	$955M	$451,000 0.01% of portfolio	40,943	Q2 2025 New
MDGL Madrigal Pharmaceuticals, Inc.	$7.39B	$428,000 0.01% of portfolio	1,415	Q2 2025 New
LCTX Lineage Cell Therapeutics, Inc.	$227M	$368,000 0.01% of portfolio	405,043	Q2 2025 New
OCUL Ocular Therapeutix, Inc	$986M	$341,000 0.01% of portfolio	36,815	Q2 2025 New
OCGN Ocugen, Inc.	$232M	$333,000 0.01% of portfolio	343,557	Q2 2025 New
ATOS Atossa Therapeutics, Inc.	$106M	$320,000 0.01% of portfolio	386,334	Q2 2025 New
ABOS Acumen Pharmaceuticals, Inc.	$55.9M	$290,000 0.01% of portfolio	250,848	Q2 2025 New
VERV Verve Therapeutics, Inc.	$667M	$289,000 0.01% of portfolio	25,736	Q2 2025 Reduced 49.97%
ITOS I Teos Therapeutics, Inc.	$361M	$282,000 0.01% of portfolio	28,375	Q2 2025 Added 56.56%
CPRX Catalyst Pharmaceuticals, Inc.	$2.05B	$272,000 0.01% of portfolio	12,571	Q2 2025 New
HLVX Hille Vax, Inc.	$69.9M	$217,000 0.01% of portfolio	109,153	Q2 2025 New
PROK Prokidney Corp Ord Shs Cl A(Cy	$153M	$207,000 0.01% of portfolio	351,622	Q2 2025 New
ARDX Ardelyx, Inc.	$1.02B	$204,000 0.01% of portfolio	52,130	Q2 2025 New
ETNB 89bio, Inc.	$375M	$175,000 0.0% of portfolio	17,876	Q2 2025 New
CRBU Caribou Biosciences, Inc.	$110M	$172,000 0.0% of portfolio	137,211	Q2 2025 New
VRDN Viridian Therapeutics, Inc.\De	$753M	$170,000 0.0% of portfolio	12,180	Q2 2025 New
NAUT Nautilus Biotechnology, Inc.	$89.8M	$161,000 0.0% of portfolio	224,456	Q2 2025 New
ETON Eton Pharmaceuticals, Inc.	$446M	$156,000 0.0% of portfolio	10,991	Q2 2025 Reduced 17.98%
VTYX Ventyx Biosciences, Inc.	$130M	$148,000 0.0% of portfolio	69,236	Q2 2025 New
PYXS Pyxis Oncology, Inc.	$63.9M	$146,000 0.0% of portfolio	133,047	Q2 2025 New
XBIT X Biotech Inc.	$85.5M	$142,000 0.0% of portfolio	47,885	Q2 2025 New
RCUS Arcus Biosciences, Inc.	$831M	$136,000 0.0% of portfolio	16,794	Q2 2025 Reduced 46.54%
AKBA Akebia Therapeutics, Inc.	$542M	$111,000 0.0% of portfolio	30,657	Q2 2025 New
TCRX T Scan Therapeutics, Inc.	$33.3M	$111,000 0.0% of portfolio	76,660	Q2 2025 New
STTK Shattuck Labs, Inc.	$84.3M	$97,000 0.0% of portfolio	123,172	Q2 2025 New
HOWL Werewolf Therapeutics, Inc.	$42.2M	$92,000 0.0% of portfolio	84,421	Q2 2025 New
ATNM Actinium Pharmaceuticals, Inc.	$41.1M	$90,000 0.0% of portfolio	64,909	Q2 2025 New
VERU Veru Inc.	$277M	$89,000 0.0% of portfolio	154,025	Q2 2025 New
CGEM Cullinan Oncology, Inc.	$298M	$83,000 0.0% of portfolio	11,129	Q2 2025 New
CCCC C4 Therapeutics, Inc.	$130M	$75,000 0.0% of portfolio	52,521	Q2 2025 New
ENOB Enochian Biosciences Inc	$244M	$66,000 0.0% of portfolio	14,515	Q2 2025 New
OVID Ovid Therapeutics Inc.	$88.7M	$52,000 0.0% of portfolio	160,306	Q2 2025 New
IPSC Century Therapeutics, Inc.	$29.4M	$50,000 0.0% of portfolio	89,975	Q2 2025 New
GBIO Generation Bio Co.	$350M	$47,000 0.0% of portfolio	148,186	Q2 2025 New
STRO Sutro Biopharma, Inc.	$45.9M	$47,000 0.0% of portfolio	66,591	Q2 2025 New
PRLD Prelude Therapeutics Inc	$41.1M	$38,000 0.0% of portfolio	47,788	Q2 2025 New
ZNTL Zentalis Pharmaceuticals, Inc.	$84.9M	$37,000 0.0% of portfolio	32,740	Q2 2025 New
MGNX Macrogenics Inc	$99.6M	$36,000 0.0% of portfolio	29,945	Q2 2025 New
BDTX Black Diamond Therapeutics, Inc.	$118M	$36,000 0.0% of portfolio	14,521	Q2 2025 New
ELEV Elevation Oncology, Inc.	$8.39M	$5,000 0.0% of portfolio	14,016	Q2 2025 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.